Navamedic gains approval for Flexilev in OraFID packaging across Nordic countries

NORWAY – Navamedic, a Nordic pharmaceutical company, has received national approvals for Flexilev in its innovative OraFID packaging across all Nordic countries, including Norway, Sweden, and Denmark, with final confirmation for the Finnish market. 

The OraFID dispenser is a patented, mechanical device designed to deliver precise doses of minitablets for Parkinson’s disease treatment. The launch in Nordic markets is anticipated in October 2025.

The OraFID dispenser offers a sustainable alternative to traditional packaging by reducing material waste and ensuring accurate dosing. 

This innovation is particularly vital for Parkinson’s patients, as it supports hyper-fractionation, administering smaller, more frequent doses, to optimize treatment for medications with a narrow therapeutic window.

 “We are excited to have received the last approvals, paving the way for our go-to-market launch in the Nordic region,” said Kathrine Gamborg Andreassen, CEO of Navamedic, in a statement.

The approval follows the initial endorsement of OraFID as a primary pharmaceutical packaging solution in June 2025, a milestone achieved after Navamedic’s acquisition of Sensidose in May 2023, which added Flexilev to its portfolio. 

In June 2024, Navamedic signed a licensing and supply agreement with Orion Corporation, granting Orion exclusive rights to market and distribute Flexilev, including OraFID, in 27 European countries, such as Germany, France, Italy, Spain, and the UK.

Navamedic retains marketing rights in Sweden, Norway, Denmark, and Iceland.

In a statement, Hao Pan, Senior Vice President of Branded Products at Orion, noted, “This agreement enhances our Parkinson’s disease portfolio, offering advanced-stage patients a tailored treatment option across Europe.” 

The deal includes a US$2.1 million upfront payment to Navamedic, with potential milestone payments of up to US$3.7 million upon reimbursement approvals in key markets, alongside royalties from net revenue.

Subscribe to our email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE